Beaver Bio Celebrates 10th Anniversary: Leading the Functional Magnetic Beads Market with Kilogram-Scale Production Capability Amid Surging IVD Raw Materials Demand
From receiving scant capital interest to becoming a hot investment, and from a niche market to a multi-billion-dollar industry, the IVD raw materials sector has undergone this transformation over the past decade.
Dr. Ren Hui, founder of Suzhou Beaver Biomedical Engineering Co., Ltd., a raw material supplier in the field of magnetic nanoparticles, is an industry veteran with over a decade of experience in the IVD raw materials market. The continuous surge in market interest over the past two years has given Dr. Ren a deeper personal appreciation for the saying, “After enduring the clouds, one finally sees the moonlight.”
“Previously, the industry focused more on the clinical market, with little willingness to invest in the upstream raw material sector. Impacted by the pandemic, the raw material industry was rapidly thrust into the spotlight, leading to a sharp increase in capital investment interest. Raw material companies successfully completed IPOs, and financing and M&A activities occurred frequently. Suzhou Beaver Biomedical Engineering Co., Ltd. also successfully completed its Series B financing, raising tens of millions of yuan.”
“In the past, the IVD raw materials market developed at a slow pace with limited R&D investment; Suzhou Beaver Biomedical Engineering Co., Ltd. used to spend only RMB 2–3 million annually on R&D. Currently, the company’s annual R&D expenditure has reached RMB 15–20 million, its scaled production capacity has increased substantially, and its growth rate has accelerated significantly.”
It is evident that the golden age of China’s IVD raw materials market has arrived.
Raw materials are the source of innovation in the IVD industry and the cornerstone for ensuring critical product performance, significantly impacting the performance and accuracy of diagnostic reagents. To develop high-end diagnostic products, it is essential to first master the processes and technologies for designing and producing core raw materials, particularly those involving magnetic beads.Dr. Ren Hui was among the first scientists in China to dedicate himself to the field of magnetic nanoparticles.
Dr. Hui Ren received his bachelor’s degree from Nankai University, then pursued a Ph.D. in Structural Biology at Peking University, and subsequently conducted postdoctoral research at the Center for Biomedical Engineering of the Massachusetts Institute of Technology (MIT) in the United States.
“During our time in the United States, we performed protein purification on a daily basis. Typically, the protein purification process relies on large-scale instrumentation and complex protocols, requiring 1–2 days to complete a single purification run; however”Magnetic Bead-Based Protein Purification: A revolutionary technological breakthrough in the field of separation and purification materials, enabling rapid completion of the protein purification process within one hour, as well as high-throughput and automated extraction.“Dr. Ren Hui remarked.”
“At that time in China, traditional column chromatography systems were still widely used for protein purification, with minimal application of magnetic nanobeads. There was a complete absence of domestic manufacturers for related products, and all magnetic nanobead products relied entirely on imports.”
Recognizing the gap in the Chinese market for nanomagnetic beads and their significant future potential, Dr. Ren Hui chose to focus on the independent research, development, and industrialization of nanomagnetic beads upon returning to China to start his business. The earliest product line developed by Beaver Biomedical was designed for protein purification. Requiring only a magnet, this system completes the protein purification process in approximately 30 minutes, offering high efficiency, convenience, and low cost. Leveraging these advantages, Beaver Biomedical quickly secured a position in the nanomagnetic bead sector.
Magnetic nanoparticles are micro- and nanospheres, with particle sizes ranging from tens of nanometers to hundreds of micrometers, composed of numerous magnetic nanoparticles encapsulated within a non-magnetic matrix (excerpted from the newly released international standard for magnetic nanoparticles, ISO/TS 19807-2:2021). Magnetic nanoparticles can achieve enrichment of target components in biological samples through surface modification or grafting of specific biofunctional groups, followed by magnetic separation to accomplish isolation and purification.
Currently, magnetic beads are widely used in various fields, including magnetic-activated cell sorting (MACS) in cell biology, antibody/protein isolation and purification, nucleic acid extraction and probe capture, immunoassays, magnetic resonance imaging (MRI), magnetic particle imaging (MPI), and nanomaterial-based catalytic reactions. With the rapid development of novel biomedicine in China, nano-magnetic beads have gradually become a core raw material for the in vitro diagnostics (IVD) industry.
Dr. Ren Hui told VCBeat that the structure and manufacturing process of nanomagnetic beads used for nucleic acid extraction are relatively simple, with more than ten manufacturers in China currentlyAchieved large-scale mass production capacity and realized domestic substitution,"Like the nucleic acid extraction kit for the novel coronavirus, most of them use domestically produced magnetic beads."The sector truly facing a chokehold is functional magnetic beads,including magnetic beads for chemiluminescent immunoassays, fragment selection magnetic beads, probe capture magnetic beads, and magnetic beads for cell sorting, among others.
Functional magnetic beads typically have a particle size range of 1–5 μm and require uniform particle size distribution. This necessitates the use of complex multi-layered structural fabrication processes, which makes large-scale production of functional magnetic beads extremely challenging.
Dr. Ren Hui stated,China Has Yet to Achieve Large-Scale Mass Production of Functional Magnetic Beads in the Past Decade, as capital attention and investment in the IVD raw materials sector have increased significantly, the industry is targeting the pain point of heavy reliance on imported brands for functional magnetic beads, striving to solve the challenges of large-scale mass production. Suzhou Beaver Biomedical Engineering Co., Ltd. (Beaver Bio) is a key player in this effort.
In China,There are also 5–10 companies with functional magnetic bead technology, but the vast majority remain at the level of small-batch production supplying the research market.Very few companies are truly capable of achieving industrial-scale mass production of functional magnetic beads.
“Only by achieving large-scale mass production can the stability of magnetic nanobeads be ensured, costs be reduced, and competitiveness against imported brands be established to withstand market tests,” stated Dr. Ren Hui.
“Unlike biochemical reagents, which can quickly enter large-scale mass production once the formulation is finalized, the production of functional magnetic beads at a scale of 10 grams versus 100 grams requires entirely different process routes and formulations. This means that,”From 1 gram, 10 grams, and 100 grams to 500 grams, and further to the kilogram scale, each upgrade in mass production capacity requires a prolonged process of process development and production testing.”
For years, Suzhou Beaver Biomedical Engineering Co., Ltd. (Beaver Biomed) has been tackling the technical challenges associated with the manufacturing process and large-scale mass production of functional magnetic beads. The complexity of producing functional magnetic beads is comparable to that of synthesizing a pharmaceutical drug. From instrumentation and reaction conditions to precise control over speed, temperature, and rotation rate, Beaver Biomed has undergone extensive trial and error.The mass production scale of functional magnetic beads has reached the kilogram level, leading domestic peers.”
In the realm of functional magnetic beads, Dynabeads, under Thermo Fisher Scientific, is undoubtedly the leading brand, offering exceptional bead performance and a highly diverse product portfolio. AndBeaver Biomedical has successfully replaced Dynabeads’ functional magnetic beads across multiple product lines, with comparable performance, specifications, and mass production capabilities.。
Currently, Beaver Biomedical has established a comprehensive portfolio in the field of magnetic nanoparticles, including nucleic acid extraction beads and immunolabeling and capture beads. The company provides nearly 100 products for biological research, molecular diagnostics, immunoassays, and immune cell therapy, such as high-quality magnetic nanoparticle raw materials, protein-conjugated intermediates, immunomagnetic beads, nucleic acid extraction kits, auxiliary biological consumables, and supporting automated equipment.Accumulated over 1,000 clients in China and overseas.
For a long time, China’s upstream raw material industry has been largely dominated by imported brands. Well-known companies include Thermo Fisher Scientific, Abcam, Meridian Life Science, Hytest, Roche, and Merck. While some in vitro diagnostics (IVD) enterprises produce a small portion of their own materials, the majority of core raw materials still rely on imports.
The outbreak of the COVID-19 pandemic has further highlighted the vulnerability of China’s IVD industry to its reliance on foreign upstream raw materials, driving rapid expansion of the domestic IVD raw material market.According to a Frost & Sullivan report, the market size of domestic IVD raw materials in China grew from RMB 3.3 billion in 2015 to RMB 8.2 billion in 2019, representing a compound annual growth rate (CAGR) of 25.8%. The market size is projected to reach RMB 20 billion in 2024, with a CAGR of 19.4% from 2019 to 2024.
Dr. Ren Hui believes: “The increasingly complex international landscape and the normalization of the pandemic are accelerating the domestic substitution of IVD raw materials.Currently, many domestic IVD manufacturers are actively seeking domestically produced alternatives to imported raw materials,IVD raw materials are expected to achieve widespread domestic substitution within five years.”
As can be seen, a large number of companies from other industries are now entering the IVD raw materials market. In contrast, Suzhou Beaver Biomedical Engineering Co., Ltd., with ten years of dedicated expertise in the field of magnetic nanoparticles, holds a stronger competitive position in this market.
As the immunodiagnostics market expands rapidly and automation accelerates, the strategic importance of functional magnetic beads in in vitro diagnostics is becoming increasingly prominent. Moving forward, Suzhou Beaver Biomedical Engineering Co., Ltd. will continue to refine its layout in the field of nanomagnetic beads, enhance R&D capabilities for functional magnetic beads and sample processing solutions, boost mass production capacity, and develop innovative products such as cell sorting kits, thereby continuously consolidating its leading position in China in terms of mass production capacity and product diversity for functional magnetic beads.